Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Bibliographic Details
Main Authors:	Karen Sheares, Stephen P Hoole, John E Cannon, Dolores Taboada, Mark Toshner, Andrew John Fletcher, Guillermo Martinez, Alessandro Ruggiero, Nicholas Screaton, Joanna Pepke-Zaba
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-06-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/7/1/e000931corr1.full

Similar Items

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
by: Karen Sheares, et al.
Published: (2020-06-01)

Correction: Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
by: Karen Sheares, et al.
Published: (2020-06-01)

Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
by: Matthew S. Rodgers, et al.
Published: (2022-10-01)

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
by: Fuwei Liu, et al.
Published: (2022-06-01)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
by: Katherine Bunclark, et al.
Published: (2021-05-01)

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
by: Enrico Guido Spinoni, et al.
Published: (2022-02-01)

Novel Oral Anti Coagulants (NOACs) as Anti Thrombotic on Atrial Fibrillation Patients
by: Abed Nego Okthara Sebayang
Published: (2020-02-01)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
by: Line Melgaard, et al.
Published: (2021-12-01)

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
by: Maurizio Paciaroni, et al.
Published: (2017-12-01)

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
by: Lu Wang, et al.
Published: (2023-08-01)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
by: Angela Saviano, et al.
Published: (2022-11-01)

Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension.
by: Gaël Deboeck, et al.
Published: (2014-01-01)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
by: Marissa K. Edmiston, et al.
Published: (2018-09-01)

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials
by: Peter A. Noseworthy, et al.
Published: (2017-10-01)

Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
by: Lorenzo Pradelli, et al.
Published: (2014-12-01)

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
by: Lorenzo Pradelli, et al.
Published: (2014-12-01)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
by: Qiyu He, et al.
Published: (2019-05-01)

Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
by: Louise C. Kirkby, et al.
Published: (2023-07-01)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
by: Hyeongsoo Kim, et al.
Published: (2020-01-01)

Acute Stroke and Atrial Fibrillation: Risk of Incorrect NOAC Dosage When Estimating Renal Function From Plasma Creatinine Only
by: Danial C. Amoey, et al.
Published: (2022-07-01)

Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
by: Victor Chien-Chia Wu, et al.
Published: (2020-01-01)

Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: an analysis from NOAC-TR study
by: Volkan Emren, et al.
Published: (2017-12-01)

Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)
by: Özer Badak, et al.
Published: (2022-04-01)

Thromboembolism and bleeding risk scores and predictors of cardiac death in a population with atrial fibrillation
by: Rose Mary Ferreira Lisboa da Silva, et al.

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
by: Komsing Methavigul
Published: (2022-06-01)

Efficacy and Safety of NOACs Compared With VKAs for Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A System Review and Meta-Analysis
by: Junye Ge MD, et al.
Published: (2022-12-01)

Some Thoughts About Warfarin and NOACS
by: C. Richard Conti
Published: (2017-01-01)

Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score
by: Paolo Prandoni
Published: (2023-10-01)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
by: Marco Proietti, et al.
Published: (2018-09-01)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
by: Paulus Kirchhof, et al.
Published: (2020-03-01)

AF-React study: Prevalence of thrombotic events in patients with atrial fibrillation receiving NOACs – real-world data analysis from northern Portugal primary healthcare
by: Susana Silva Pinto, et al.
Published: (2024-04-01)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
by: Jo-Nan Liao, et al.
Published: (2022-01-01)

Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
by: Beshir, Semira Abdi, et al.
Published: (2017)

Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
by: Kourosh Ravvaz, et al.
Published: (2021-01-01)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
by: Zei Li, et al.
Published: (2022-06-01)

Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR
by: Sadik Volkan Emren, et al.
Published: (2020-01-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
by: Alina Scridon, et al.
Published: (2023-04-01)